GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. The company is headquartered in Stamford, Connecticut.

GeneDx Holdings Corp.

In a report released today, Mark Massaro from BTIG reiterated a Buy rating on GeneDx Holdings, with a price target of $200.00. According to TipRank...

BTIG Sticks to Its Buy Rating for GeneDx Holdings (WGS)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Kymera Therapeutics (KYMR – Research Report), GeneDx...

Analysts Are Bullish on These Healthcare Stocks: Kymera Therapeutics (KYMR), GeneDx Holdings (WGS)

Cathie Wood’s ARK Invest ETFs (exchange-traded funds) made notable portfolio moves on Monday, January 12, as revealed in daily fund disclosures. Th...

Cathie Wood Doubles Down on High-Potential Biotech Plays

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Alnylam Pharma (ALNY – Research Report), GeneDx Ho...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Alnylam Pharma (ALNY), GeneDx Holdings (WGS) and Masimo (MASI)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Quanterix (QTRX – Research Report), Indivior (INDV – Research Rep...

Current Yield	N/A	Payout Ratio	0.00%
Annual DPS	$0.00	Growth Streak	0 years
Ex-Dividend	Invalid Date	Pay Date	Invalid Date
Frequency	NA	Quarterly Est	$0.00

	A	B	C	D
1	Symbol	Price	Change	Volume
2	WGS	$95.95	-3.09%	348.35K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	WGS	$95.95	-3.1%	348.35K
3
4
5
6

WGS

WGS

Dividend Overview

Get GeneDx Holdings Corp. Data in Excel

Get GeneDx Holdings Corp. Data in Excel